INN Blog

More Posts
 

PartnerRe to Delist on NYSE Euronext Paris [Health & Beauty Close - Up]

Proquest LLC

PartnerRe said that it will delist its shares from NYSE Euronext Paris, effective Jan. 18.

In a release, the Company said that its shares will continue to be traded on the New York Stock Exchange.

PartnerRe said that it made the decision to delist the shares traded on NYSE Euronext Paris as a result of low trading volumes over the past three years. PartnerRe announced the cross-listing in Paris in December 2009, as a result of the acquisition of Paris Re, to provide investors with a Euro-denominated, European-listed trading platform, in addition to PartnerRe's U.S. Dollar listing on NYSE.

The delisting was recently approved by the Board of Directors of Euronext Paris S.A. Further details on the delisting process will be disclosed in an official notification from NYSE Euronext Paris on Dec. 14, on the NYSE website at europeanequities.nyx.com/en/ products/equities/BMG6852T1053-XPAR.

PartnerRe is a reinsurer, providing multi-line reinsurance to insurance companies.

((Comments on this story may be sent to health@closeupmedia.com))

Copyright:(c) 2012 ProQuest Information and Learning Company; All Rights Reserved.
Wordcount:159



USER COMMENTS:

comments powered by Disqus

  More Newswires

More Newswires >>
  Most Popular Newswires

More Popular Newswires >>
Hot Off the Wires  Hot off the Wires

More Hot News >>

insider icon Denotes premium content. Learn more about becoming an Insider here.
For Clients with Prostate Cancer